FIECON Patient Perspectives

Jan 04 2024
FIECON Patient Perspectives Podcast artwork

In our series of podcasts, FIECON team members engage with patient advocates and thought leaders to explore the burden, unmet needs, patient journey, and potential future treatments for specific diseases, with the aim of gaining a deeper understanding of the patient's perspective, particularly for rare diseases. At FIECON, we are dedicated to ensuring that life-changing treatments reach the patients who truly need them, while also increasing awareness and amplifying the patient voice to make a meaningful difference.

RSS feed Share
Copy RSS


Subscribe on Podcast Addict


The patient journey | Von Hippel-Lindau syndrome (VHL)

Jan 04 2024 17 mins  
Von Hippel-Lindau syndrome (VHL), is an inherited condition that brings about tumors in various organs, particularly hemangioblastomas, which are blood vessel tumors found in the brain, spinal cord, and retina. Listen to FIECON's latest 'Patient Perspectives' podcast with Lauren Weinberg, Senior Associate at FIECON, talking to Frankie Bryant about her journey living wit

The patient journey | Leber hereditary optic neuropathy (LHON)

Sep 20 2023 17 mins  
In this podcast, Lily Mumford talks to Lauren Weinberg, Senior Associate at FIECON, about her patient journey, experience living with LHON, and how losing her vision has impacted her life. Leber hereditary optic neuropathy (LHON) is a rare condition that primarily affects young adults. It causes painless vision loss, typically starting in one eye and later affecting the other eye w

The patient journey | FOP (Fibrodysplasia Ossificans Progressiva ), Lexi's story

Aug 30 2023 29 mins  
In this podcast, David Robins talks to Lauren Weinberg, Senior Associate at FIECON, about the patient journey, his experience as the father of Lexi who lives with Fibrodysplasia Ossificans Progressiva (FOP), and as a family after the FOP diagnosis. FOP is an ultra-rare genetic condition and is one of the most debilitating conditions known to medicine. FOP causes the soft connective

The patient journey | SATB2-associated syndrome (SAS)

Jun 16 2023 21 mins  
Erika Stariha is the mother of the first child in Slovenia diagnosed with SATB2-associated syndrome (SAS), as well as the founder and president of SATB2-Europe. SATB2 Europe's aim is:“To improve quality of life for individuals with SATB2 syndrome through discovery and development of targeted treatments and enhanced availability of appropriate care”. SATB-2 associated (also

The patient journey | Acanthamoeba keratitis

Nov 24 2022 34 mins  
Juliette Vila Sinclair-Spence is a passionate Acanthamoeba keratitis (AK) Warrior and Rare Disease Patient Advocate as well as the Founder and Chairwoman of Acanthamoeba keratitis (AK) Eye Foundation. With her patient voice, she brings personal and first-hand experience of what it means to be affected by Acanthamoeba keratitis as well as its aftermath.Her goal is to raise awareness

The patient journey | Dravet syndrome

Feb 28 2022 24 mins  
José Ángel Aibar became involved in the activities of the Dravet Syndrome Foundation, shortly after one of his sons was diagnosed with Dravet syndrome. He has served as President and CEO since June 2018. José is also a member of several rare disease and epilepsy working groups, such as Epag EpiCARE and the Eurordis Digital and Data Advisory Group, as well as a member of the advi

Access for rare diseases - how to navigate conflict, compromise and collaboration

Jan 31 2022 35 mins  
World Orphan Drug Congress panel discussion November 2021 "Access for rare diseases - how to navigate conflict, compromise and collaboration" with panellists - Karl Freemyer, Head of Business Development - FIECON (host)Martin Schuchardt, Director of Pricing and Market Access - FIECONSimon Eade, Vice president of Worldwide global strategy - Janssen Oriol Sola-Morales, CEO

The patient journey | Pompe disease

Sep 15 2021 47 mins  
Pompe disease is a rare (estimated at 1 in every 40,000 births), inherited and often fatal disorder that disables the heart and skeletal muscles. It is caused by mutations in a gene that makes an enzyme called acid alpha-glucosidase (GAA). Normally, the body uses GAA to break down glycogen, a stored form of sugar used for energy.Infantile Pompe disease is the result of complete or

The patient journey | Fibrodysplasia Ossificans Progressiva (FOP)

Aug 12 2021 26 mins  
Chris and Helen Bedford - Gay are the founders and patient advocacy leaders at FOP Friends charity. In 2009 their first child, Oliver, was diagnosed with FOP, aged just one.FOP Friends’ aim is to further research into Fibrodysplasia Ossificans Progressiva (FOP) and related conditions by supporting current and future research projects. In this podcast they talk to us about the pat

The patient journey | ATTR (transthyretin) amyloidosis and wild type amyloidosis disease

May 18 2021 33 mins  
Vince Nicholas and Paul Pozzo are patient advocacy leaders at the UK ATTR amyloidosis Patient Association. Each live with a variant of the rare disease amyloidosis; ATTR (transthyretin) amyloidosis and wild-type amyloidosis, respectively. In this podcast they talk to us about their patient journey and their experiences as both patients and patient advocacy leaders.Amyloidosis is a